Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Meet with a physician to verify BMI and diagnoses met the criteria at the time GLP-1 therapy was initiated (which may precede participation in the Bridge program)
Sano, S
Over a 12-week period, the participants were randomized to receive dulaglutide 1.5 mg, placebo, or once-weekly subcutaneous injections of LY3437943
The most common are gastrointestinalnausea, a feeling of excessive fullness, constipation, or diarrhea
Nat Rev Endocrinol, 2018, Vol 14(7), pp 390403
doi: 10.1016/j.neuropharm.2014.10.007 73 Aviles-OlmosIDicksonJKefalopoulouZDjamshidianAEllPSoderlundTet al
US$ 20.79
US$ 23.46
US$ 26.21
US$ 25.25
US$ 28.63
US$ 21.37
US$ 23.36
